Operating Lease, Right-of-Use Asset of ACADIA PHARMACEUTICALS INC from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ACADIA PHARMACEUTICALS INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • ACADIA PHARMACEUTICALS INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $49,673,000, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ACADIA PHARMACEUTICALS INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $49,673,000 +$5,420,000 +12% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $50,991,000 -$1,399,000 -2.7% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $50,614,000 -$3,666,000 -6.8% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $46,571,000 -$5,284,000 -10% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $44,253,000 -$6,505,000 -13% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $52,390,000 +$8,000 +0.02% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $54,280,000 +$129,000 +0.24% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $51,855,000 -$3,718,000 -6.7% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $50,758,000 -$5,866,000 -10% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $52,382,000 -$5,035,000 -8.8% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $54,151,000 -$4,035,000 -6.9% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $55,573,000 -$2,695,000 -4.6% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $56,624,000 -$3,408,000 -5.7% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $57,417,000 -$3,954,000 -6.4% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $58,186,000 -$4,925,000 -7.8% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $58,268,000 +$10,985,000 +23% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $60,032,000 +$11,800,000 +24% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $61,371,000 +$53,491,000 +679% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $63,111,000 +$54,498,000 +633% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $47,283,000 +$37,759,000 +396% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $48,232,000 +$38,273,000 +384% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 $7,880,000 -$2,938,000 -27% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $8,613,000 -$2,305,000 -21% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $9,524,000 +$9,524,000 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $9,959,000 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $10,818,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $10,918,000 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 27 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.